Richard C. Pfenniger Jr.
CIK: 0001200796
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 18, 2026WGS
GeneDx Holdings Corp.
Award(A)DirectRestricted Stock Unit
4.2K shares- - Jun 18, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct3.6K shares- - Jun 18, 2026OPK
OPKO HEALTH, INC.
Award(A)DirectStock Option (Right to Buy)
60K shares- - Jun 17, 2026FLNT
Fluent, Inc.
Award(A)Direct30.1K shares- - Jan 9, 2026COCP
Cocrystal Pharma, Inc.
Award(A)DirectStock Options (Right to Buy)
16.4K shares- - Oct 28, 2025COCP
Cocrystal Pharma, Inc.
Award(A)Direct20K shares- - Jun 18, 2025WGS
GeneDx Holdings Corp.
Award(A)DirectRestricted Stock Unit
3.6K shares- - Jun 18, 2025WGS
GeneDx Holdings Corp.
Exercise(M)Direct12.9K shares- - Jun 18, 2025FLNT
Fluent, Inc.
Award(A)Direct39.7K shares- - May 2, 2025WGS
GeneDx Holdings Corp.
Exercise(M)Direct918 shares- - Apr 23, 2025OPK
OPKO HEALTH, INC.
Award(A)DirectStock Option (Right to Buy)
60K shares- - Oct 9, 2024COCP
Cocrystal Pharma, Inc.
Award(A)Direct8.1K shares- - Jun 4, 2024FLNT
Fluent, Inc.
Award(A)Direct21.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  WGS GeneDx Holdings Corp. | Award(A) Restricted Stock Unit | 4,248 | - | - | Direct |
| Jun 18, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 3,576 | - | $0 | Direct |
| Jun 18, 2026 |  OPK OPKO HEALTH, INC. | Award(A) Stock Option (Right to Buy) | 60,000 | - | - | Direct |
| Jun 17, 2026 |  FLNT Fluent, Inc. | Award(A) | 30,096 | - | $0 | Direct |
| Jan 9, 2026 |  COCP Cocrystal Pharma, Inc. | Award(A) Stock Options (Right to Buy) | 16,410 | - | - | Direct |
| Oct 28, 2025 | COCP Cocrystal Pharma, Inc. | Award(A) | 20,000 | - | - | Direct |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | Award(A) Restricted Stock Unit | 3,576 | - | - | Direct |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | Exercise(M) | 12,924 | - | - | Direct |
| Jun 18, 2025 | FLNT Fluent, Inc. | Award(A) | 39,682 | - | - | Direct |
| May 2, 2025 | WGS GeneDx Holdings Corp. | Exercise(M) | 918 | - | - | Direct |
| Apr 23, 2025 | OPK OPKO HEALTH, INC. | Award(A) Stock Option (Right to Buy) | 60,000 | - | - | Direct |
| Oct 9, 2024 | COCP Cocrystal Pharma, Inc. | Award(A) | 8,067 | - | $0 | Direct |
| Jun 4, 2024 | FLNT Fluent, Inc. | Award(A) | 21,429 | - | $0 | Direct |
1-13 of 13 transactions
About PFENNIGER RICHARD C JR
PFENNIGER RICHARD C JR (SEC CIK 0001200796) files insider reports with the SEC as Director of GeneDx Holdings Corp. (WGS), Director of OPKO HEALTH, INC. (OPK) and Director of Fluent, Inc. (FLNT). Signal8 also holds filings tied to 1 other company.
Signal8 holds 11 ownership filings by PFENNIGER RICHARD C JR, all Form 4s, filed between Oct 11, 2024 and Jun 23, 2026. Those filings report 13 transactions, from Jun 4, 2024 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PFENNIGER RICHARD C JR's filings is in NEW YORK, NY.
Recent filings by PFENNIGER RICHARD C JR
- Jun 18, 2026: Grant or award of WGS derivative securities (Form 4, code A).
- Jun 18, 2026: Option exercise of WGS shares (Form 4, code M).
- Jun 18, 2026: Grant or award of OPK derivative securities (Form 4, code A).
- Jun 17, 2026: Grant or award of FLNT shares (Form 4, code A).
- Jan 9, 2026: Grant or award of COCP derivative securities (Form 4, code A).
Other insiders filing for GeneDx Holdings Corp. (WGS)
- Stueland Katherine, CHIEF EXECUTIVE OFFICER
- Feeley Kevin, CHIEF FINANCIAL OFFICER
- Fuchs Thomas, Director
- GARDNER MARK A, President
- Ryan Jason, Director
- RUCH JOSHUA, Director